AUS
NZ
UK
CA
USA
IND
Highlights
- dorsaVi introduces an advanced 3D knee assessment tool.
- Technology leverages AI and FDA-cleared wearable sensors for injury risk analysis.
- New solution targets elite sports, physiotherapy, and rehabilitation markets.
dorsaVi (ASX:DVL) has unveiled an innovative 3D motion analysis test designed to enhance knee injury prevention and rehabilitation. This cutting-edge technology utilizes FDA-cleared wearable sensors and artificial intelligence to assess movement patterns linked to anterior cruciate ligament (ACL) injury risks. The newly launched tool builds upon a database of over 10,000 knee assessments, providing advanced insights for athletes, physiotherapists, and rehabilitation specialists.
A Breakthrough in Motion Analysis
Traditional knee assessments often rely on 1D force plates, which primarily measure vertical force. The latest 3D motion analysis test from dorsaVi introduces a more comprehensive evaluation by capturing rotational torque forces—key factors contributing to ACL injuries. This leap in technology offers a deeper understanding of knee mechanics, enhancing early detection and prevention strategies for injury-prone individuals.
The system’s AI-driven capabilities enable real-time data processing, providing actionable insights that were previously limited to biomechanics laboratories. With this portable and accessible solution, sports teams, rehabilitation centers, and physiotherapy clinics can conduct highly accurate knee assessments without the need for complex lab setups.
Expanding Market Potential
The introduction of this technology creates significant growth potential across multiple sectors. The demand for advanced injury prevention tools is rising, particularly in elite sports, where ACL injuries can have career-altering consequences. Additionally, physiotherapy clinics and rehabilitation centers are expected to benefit from the enhanced precision and accessibility of the motion analysis tool.
Given the size of the sports medicine and rehabilitation market, which spans billions of dollars globally, the new technology positions dorsaVi as a key player in next-generation injury prevention and treatment solutions.
Executive Insights on Innovation
Dr. Andrew Ronchi, Chief Executive Officer of dorsaVi, highlighted the transformative potential of the new technology, stating that it represents a major shift in sports injury prevention. The AI-driven 3D motion analysis provides an unparalleled level of accuracy, allowing for clinic-based assessments that were previously only possible in high-end biomechanics labs.
With a focus on setting new industry standards, dorsaVi aims to make its innovative knee assessment tool a fundamental part of ACL injury prevention and rehabilitation programs worldwide. As adoption increases, the impact on athlete performance and long-term joint health could be significant.
